Secondhand smoking, 4-aminobiphenyl, and bladder cancer: Two meta-analyses

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 4, 2009, Pages 1312-1320

  Van Hemelrijck, Mieke J J ^a,b,e   Michaud, Dominique S ^a,c   Connolly, Gregory N ^a   Kabir, Zubair ^a,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d Research Institute for a Tobacco Free Society   (Ireland)

^e GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 BIPHENYLAMINE;

ARTICLE; BLADDER CANCER; BLOOD LEVEL; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CORRELATION ANALYSIS; EMBASE; ENVIRONMENTAL EXPOSURE; HUMAN; MEDLINE; PASSIVE SMOKING; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL MODEL; URINE LEVEL;

ADULT; AMINOBIPHENYL COMPOUNDS; CASE-CONTROL STUDIES; CHILD; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; RISK FACTORS; TOBACCO SMOKE POLLUTION; URINARY BLADDER NEOPLASMS;

EID: 66749134765     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0613     Document Type: Article

References (28)

1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005;16:481-488
2. Silverman D, Devesa S, Moore L, Rothman N. Bladder cancer. In: Schottenfeld D, Fraumeni J, editors. Cancer epidemiology and prevention. Oxford: Oxford University press; 2006.
3. Kogevinas M, Trichopoulos D. Bladder cancer. Textbook of cancer epidemiology. London: Oxford University Press; 2002.
4. Skipper P, Tannenbaum S, Ross RY, MC. Nonsmoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2003;12:503-507
5. Vineis P, Caporaso N. Tobacco and cancer: epidemiology and the laboratory. Environ Health Perspect 1995;103:156-160
6. Bjerregaard BK, Raaschou-Nielsen O, Sorensen M, et al. Tobacco smoke and bladder cancer-in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2006;119:2412-2416 (Pubitemid 44546965)
7. Pitard A, Brennan P, Clavel J, et al. Cigar, pipe, and cigarette smoking and bladder cancer risk in European men. Cancer Causes Control 2001;12:551-556 (Pubitemid 32735127)
8. Samanic C, Kogevinas M, Dosemeci M, et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev 2006; 15:1348-1354 (Pubitemid 44125293)
9. Martone T, Airoldi L, Magagnotti C, et al. 4-Aminobiphenyl-DNA adducts and p53mutations in bladder cancer. Int J Cancer 1998;75: 512-516 (Pubitemid 28094094)
10. Landi MT, Zocchetti C, Bernucci I, et al. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl- hemoglobin adduct levels. Cancer Epidemiol Biomarkers Prev 1996;5:693-698 (Pubitemid 26304643)
11. Saletta F, Matullo G, Manuguerra M, Arena S, Bardelli A, Vineis P. Exposure to the tobacco smoke constituent 4-aminobiphenyl induces chromosomal instability in human cancer cells. Cancer Res 2007;67: 7088-7094 (Pubitemid 47206535)
12. Vineis P, Pirastu R. Aromatic amines and cancer. Cancer Causes Control 1997;8:346-355 (Pubitemid 27297802)
13. Bartsch H, Malaveille C, Friesen M, Kadlubar FF, Vineis P. Black (aircured) and blond (flue-cured) tobacco cancer risk. IV. Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer 1993;29A:1199-1207
14. Malaveille C, Vineis P, Esteve J, et al. Levels of mutagens in the urine of smokers of black and blond tobacco correlate with their risk of bladder cancer. Carcinogenesis 1989;10:577-586 (Pubitemid 19089928)
15. Vineis P. The use of biomarkers in epidemiology: the example of bladder cancer. Toxicol Lett 1992;64-65 Spec No:463-467 (Pubitemid 23018786)
16. Hammond SK, Coghlin J, Gann PH, et al. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers. J Natl Cancer Inst 1993;85:474-478 (Pubitemid 23084092)
17. Bartsch H, Caporaso N, Coda M, et al. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. J Natl Cancer Inst 1990;82:1826-1831
18. Jiang X, Yuan JM, Skipper PL, Tannenbaum SR, Yu MC. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res 2007;67:7540-7545 (Pubitemid 47206585)
19. Maclure M, Katz RB, Bryant MS, Skipper PL, Tannenbaum SR. Elevated blood levels of carcinogens in passive smokers. Am J Public Health 1989;79:1381-1384 (Pubitemid 19239138)
20. Richter E, Rosler S, Scherer G, et al. Haemoglobin adducts from aromatic amines in children in relation to area of residence and exposure to environmental tobacco smoke. Int Arch Occup Environ Health 2001;74:421-428 (Pubitemid 32780721)
21. Tang D, Warburton D, Tannenbaum SR, et al. Molecular and genetic damage from environmental tobacco smoke in young children. Cancer Epidemiol Biomarkers Prev 1999;8:427-431 (Pubitemid 29230547)
22. Grimmer G, Dettbarn G, Seidel A, Jacob J. Detection of carcinogenic aromatic amines in the urine of non-smokers. Sci Total Environ 2000; 247:81-90. (Pubitemid 30068687)
23. Bekkering GE, Harris RJ, Thomas S, et al. How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis? Am J Epidemiol 2008;167:1017-1026
24. Alberg AJ, Kouzis A, Genkinger JM, et al. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke. Am J Epidemiol 2007;165:660-666 (Pubitemid 46348371)
25. Chen YC, Su HJ, Guo YL, Houseman EA, Christiani DC. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer. Cancer Causes Control 2005;16: 75-81. (Pubitemid 40685053)
26. Kabat GC, Dieck GS, Wynder EL. Bladder cancer in nonsmokers. Cancer 1986;57:362-367 (Pubitemid 16212044)
27. Zeegers MP, Goldbohm RA, van den Brandt PA. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands). Cancer Causes Control 2002;13:83-90. (Pubitemid 34163954)
28. Burch JD, Rohan TE, Howe GR, et al. Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer 1989;44:622-628 (Pubitemid 19258734)